According to Zacks, “IntriCon designs, develops, engineers and manufactures microminiaturized medical and electronic products. The Company supplies microminiaturized components, systems and molded plastic parts, primarily to the hearing instrument manufacturing industry, as well as the computer, government, electronics, telecommunications and medical equipment industries. The Company has facilities in the United States, Asia and Europe. “
Several other brokerages have also recently weighed in on IIN. Stifel Nicolaus set a $36.00 price target on IntriCon and gave the company a buy rating in a research report on Friday, July 19th. B. Riley set a $36.00 target price on IntriCon and gave the stock a buy rating in a research report on Friday, July 19th. Finally, ValuEngine upgraded IntriCon from a hold rating to a buy rating in a research report on Thursday, August 1st. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $38.75.
A number of institutional investors have recently bought and sold shares of IIN. Emerald Mutual Fund Advisers Trust purchased a new position in IntriCon during the first quarter worth about $4,399,000. Marshall Wace LLP grew its position in IntriCon by 51.4% during the first quarter. Marshall Wace LLP now owns 244,688 shares of the technology company’s stock worth $6,137,000 after buying an additional 83,103 shares in the last quarter. Roubaix Capital LLC grew its position in IntriCon by 141.8% during the second quarter. Roubaix Capital LLC now owns 141,301 shares of the technology company’s stock worth $3,301,000 after buying an additional 82,867 shares in the last quarter. Gamco Investors INC. ET AL grew its position in IntriCon by 288.1% during the second quarter. Gamco Investors INC. ET AL now owns 93,919 shares of the technology company’s stock worth $2,194,000 after buying an additional 69,719 shares in the last quarter. Finally, Kennedy Capital Management Inc. purchased a new position in IntriCon during the first quarter worth about $1,697,000. Institutional investors and hedge funds own 72.43% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Read More: What is systematic risk?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.